Supplemental Financial Information (Tables)

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of noncash investing and financing activities

The following table presents the noncash investing and financing activities (amounts in thousands):

	For the nine months ended September 30,
	2019			2018
Employee benefits paid in Class A common stock	$	6,654		$	7,605
Increase (decrease) in capital expenditures included in accounts payable, net	$	(15,083	)	$	17,058
Noncash net assets exchanged for BSS Transaction (Note 5)	$	535,211		$	—

Schedule of cost of sales and research and development costs

The table below summarizes the research and development costs incurred in connection with customers’ orders included in cost of sales and other expenses we incurred for research and development (amounts in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
	2019		2018		2019		2018
Cost of sales	$	6,564	$	5,555	$	18,275	$	18,443
Research and development	$	6,136	$	6,544	$	19,411	$	20,328

Schedule of supplemental cash flows from discontinued operations

Significant supplemental cash flow information and adjustments to reconcile net income to net cash flow from operating activities for discontinued operations for the nine months ended September 30, 2019 and 2018 are as below:

	For the nine months ended September 30,
	2019			2018
Operating Activities
Net income from discontinued operations	$	46,423		$	76,843
Depreciation and amortization	$	97,435		$	105,821
Investing Activities
Expenditures for property and equipment	$	(510	)	$	(104	)
Financing Activities
Repayment of lease obligations	$	29,588		$	26,545
Repayment of in-orbit incentive obligations	$	3,440		$	3,245